Korean Post-marketing Surveillance for Xeljanz XR — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Korean Post-marketing Surveillance for Xeljanz XR — Stella

Home/Active Moderate to Severe Rheumatoid Arthritis/

View on ClinicalTrials.gov

Recruiting

Back to Active Moderate to Severe Rheumatoid Arthritis trials

Trial locations(1 site)

South Korea

Pfizer, Seoul

Key details

Sponsor

Pfizer

Enrollment target

~200 participants

Started

January 2022

Primary completion

June 2026

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.